CARNOVALE, CARLA
CARNOVALE, CARLA
Dipartimento di Scienze Biomediche e Cliniche
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement
2024 M. Fusaroli, F. Salvo, B. Begaud, T.M. Alshammari, A. Bate, V. Battini, A. Brueckner, G. Candore, C. Carnovale, S. Crisafulli, P.M. Cutroneo, C. Dolladille, M. Drici, J. Faillie, A. Goldman, M. Hauben, M.T. Herdeiro, O. Mahaux, K. Manlik, F. Montastruc, Y. Noguchi, G.N. Norén, R. Noseda, I.J. Onakpoya, A. Pariente, E. Poluzzi, M. Salem, D. Sartori, N.T.H. Trinh, M. Tuccori, F. van Hunsel, E. van Puijenbroek, E. Raschi, C. Khouri
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS
2024 M. Fusaroli, V. Giunchi, V. Battini, S. Puligheddu, C. Khouri, C. Carnovale, E. Raschi, E. Poluzzi
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review
2024 M. Cocco, C. Carnovale, E. Clementi, M.A. Barbieri, V. Battini, M. Sessa
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration
2024 M. Fusaroli, F. Salvo, B. Begaud, T.M. Alshammari, A. Bate, V. Battini, A. Brueckner, G. Candore, C. Carnovale, S. Crisafulli, P.M. Cutroneo, C. Dolladille, M. Drici, J. Faillie, A. Goldman, M. Hauben, M.T. Herdeiro, O. Mahaux, K. Manlik, F. Montastruc, Y. Noguchi, G.N. Norén, R. Noseda, I.J. Onakpoya, A. Pariente, E. Poluzzi, M. Salem, D. Sartori, N.T.H. Trinh, M. Tuccori, F. van Hunsel, E. van Puijenbroek, E. Raschi, C. Khouri
Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults
2024 G. Cirnigliaro, V. Battini, M. Castiglioni, M. Renne, G. Mosini, S. Cheli, C. Carnovale, B. Dell'Osso
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues
2024 V. Battini, M.A. Barbieri, C. Carnovale, E. Spina, E. Clementi, M. Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug–Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure
2024 V. Battini, M. Cocco, M.A. Barbieri, G. Powell, C. Carnovale, E. Clementi, A. Bate, M. Sessa
A novel approach for pharmacological substantiation of safety signals using plasma concentrations of medication and administrative/healthcare databases: A case study using Danish registries for an FDA warning on lamotrigine
2023 W. Wang, V. Battini, C. Carnovale, R. Noordam, K.W. van Dijk, K.H. Kragholm, D. van Heemst, H. Soeorg, M. Sessa
Updated Considerations for the Immunopharmacological Aspects of the “Talented mRNA Vaccines”
2023 C. Perrotta, C. Fenizia, C. Carnovale, M. Pozzi, D. Trabattoni, D. Cervia, E. Clementi
On the potential of drug repurposing in dysphagia treatment: New insights from a real-world pharmacovigilance study and a systematic review
2023 V. Battini, S. Rocca, G. Guarnieri, A. Bombelli, M. Gringeri, G. Mosini, M. Pozzi, M. Nobile, S. Radice, E. Clementi, A. Schindler, C. Carnovale, N. Pizzorni
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study
2023 M. Fusaroli, V. Giunchi, V. Battini, M. Gringeri, R. Rimondini, M. Menchetti, S. Radice, M. Pozzi, M. Nobile, E. Clementi, F. De Ponti, C. Carnovale, E. Raschi, E. Poluzzi
Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System
2023 V. Battini, C. Carnovale, E. Clementi, M. Sessa
The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase
2023 V. Battini, R.P. Van Manen, M. Gringeri, G. Mosini, G. Guarnieri, A. Bombelli, M. Pozzi, M. Nobile, S. Radice, E. Clementi, C. Carnovale
The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression
2023 V. Battini, G. Cirnigliaro, R. Leuzzi, E. Rissotto, G. Mosini, B. Benatti, M. Pozzi, M. Nobile, S. Radice, C. Carnovale, B. Dell'Osso, E. Clementi
Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS
2023 V. Battini, G. Cirnigliaro, L. Giacovelli, M. Boscacci, S. MASSARA MANZO, G. Mosini, G. Guarnieri, M. Gringeri, B. Benatti, E.G.I. Clementi, D. Bernardo, C. Carnovale
Barriers to the use of three-month Paliperidone Palmitate formulation: a study from an Italian real-world setting
2023 G. Cirnigliaro, V. Battini, R. Cafaro, G. Mosini, S. Vanzetto, T. Prodi, M. Macellaro, R. Leuzzi, D. Conti, C. Carnovale, B. Dell'Osso
Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents
2023 C. Carnovale, V. Battini, C. Santoro, M.P. Riccio, S. Carucci, M. Nobile, P. Formisano, C. Bravaccio, A. Zuddas, E. Clementi, M. Pozzi, S. Pisano
Antibiotic-Induced Neutropenia in Pediatric Patients: New Insights From Pharmacoepidemiological Analyses and a Systematic Review
2022 V. Battini, A. Mari, M. Gringeri, F. Casini, F. Bergamaschi, G. Mosini, G. Guarnieri, M. Pozzi, M. Nobile, G.V. Zuccotti, E. Clementi, S. Radice, V. Fabiano, C. Carnovale
Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review
2022 C. Carnovale, V. Battini, M. Gringeri, M. Volonté, M.C. Uboldi, A. Chiarenza, G. Passalacqua
Reply to: correspondence on "Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis"
2022 M. Gringeri, V. Battini, G. Cammarata, G. Mosini, G. Guarnieri, C. Leoni, M. Pozzi, S. Radice, E. Clementi, C. Carnovale